Covered recipient · General Payments record
MICHAEL J HAVEN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$806.37
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $263.83 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $109.65 | 1 |
| Astellas Pharma US Inc | $43.47 | 2 |
| Exact Sciences Corporation | $31.63 | 2 |
| ABBVIE INC. | $29.18 | 2 |
| Novo Nordisk AS | $19.19 | 1 |
| GlaxoSmithKline, LLC. | $16.63 | 1 |
| Lucid Diagnostics Inc. | $14.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.01 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107306347 | CMS |
| ABBVIE INC. | $14.17 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107306349 | CMS |
| Astellas Pharma US Inc | $24.64 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139466700 | CMS |
| Astellas Pharma US Inc | $18.83 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139501408 | CMS |
| AstraZeneca Pharmaceuticals LP | $109.65 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105662694 | CMS |
| Exact Sciences Corporation | $15.79 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114470301 | CMS |
| Exact Sciences Corporation | $15.84 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114470306 | CMS |
| GlaxoSmithKline, LLC. | $16.63 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116452419 | CMS |
| Lucid Diagnostics Inc. | $14.08 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152303111 | CMS |
| Novo Nordisk Inc | $19.19 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100336122 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.